Table 3.
Cholecystitis patients characteristics.
| Year | p-value | |||||
|---|---|---|---|---|---|---|
| 2019 | 2020 | 2021 | 2019 vs. 2020 | 2020 vs. 2021 | 2019 vs. 2021 | |
| Male gender n (%) | 102 (60) | 76 (58.5) | 115 (52.3) | 0.881 | 0.311 | 0.155 |
| Age (years) median (IQR) | 66 (54.7–78.2) | 70 (53–79) | 64 (48–79) | 0.422* | ||
| CCI median (IQR) | 3 (1–5) | 3 (1–5) | 2 (1–5) | 0.327* | ||
| Delay > 7 days n (%) | 22 (12.9) | 22 (16.8) | 24 (11.5) | 0.439 | 0.219 | 0.784 |
| Severity at diagnosis | ||||||
| Mild n (%) | 70 (41.4) | 45 (34.6) | 107 (48.9) | 0.431 | 0.006 | 0.135 |
| Moderate n (%) | 82 (48.5) | 68 (52.3) | 100 (45.7) | |||
| Severe n (%) | 17 (10.1) | 17 (13.1) | 12 (5.5) | |||
| Surgical treatment n (%) | 115 (67.6) | 41 (31.3) | 150 (68.8) | < 0.001 | < 0.001 | 0.894 |
| Laparoscopic approach n (%) | 106 (92.2) | 37 (90.2) | 141 (94.0) | 0.745 | 0.482 | 0.734 |
| Length of stay (days) median (IQR) | 4 (3–7.2) | 6 (4–10) | 4 (2–7) | 0.002 | < 0.001 | 0.821 |
| Complications (any grade) n (%) | 28 (16.5) | 33 (25.2) | 33 (15.0) | 0.085 | 0.026 | 0.798 |
| Severe complications (grade 3–5) n (%) | 14 (8.2) | 10 (7.6) | 11 (5.0) | 1 | 0.439 | 0.278 |
| Mortality n (%) | 3 (1.8) | 5 (3.8) | 4 (1.8) | 0.301 | 0.303 | 1 |
CCI Charlson Comorbidity Index.
*Non-significant p-value in Kruskal–Wallis test, therefore no multiple comparations were performed.